- BioRN Network
- Cluster Management
About 80 companies from the field of red biotechnology develop drugs, technology platforms and diagnostics at the Biotech Cluster Rhine-Neckar (BioRN). Globally acting healthcare companies as well as internationally renowned research institutes also play a significant part in this development.
With its focus on personalized medicine and cancer research the BioRN cluster occupies a leading position in Germany. In 2008 it was awarded the leading-edge cluster for “Cell based and molecular medicine in the Rhine-Neckar Metropolitan Region”
Oktober 22, 2014
EMBL: Chamber of secrets
Oktober 20, 2014
DKFZ Chairman and Director Otmar D. Wiestler has been elected Helmholtz President
Oktober 16, 2014
Red carpet for Stefan Hell at the DKFZ
Read our monthly BioRN Newsletter. It will keep you informed about what´s going on in the BioRN cluster.
» Find further future events here